Back
Open Access

Plasma galectin-3 as a novel biomarker to cardiac events in very high-risk atherosclerotic cardiovascular disease population: a prospective study in an upper-middle-income country

Session: Poster session 3 - Understanding cardiovascular risk development: novel mechanisms (2)
Topic: Epidemiology, Prognosis, Outcome
Speaker: Mr F. Qhabibi (West Jakarta, ID)
Event: ESC Preventive Cardiology 2024

Congress Presentation

Add to my library

Like

About the speaker

Mr Faqrizal Ria Qhabibi

West Jakarta (Indonesia)
0 follower

6 more presentations in this session

Discussants - Understanding cardiovascular risk development: novel mechanisms (2)

Access
Like
Thumbnail

Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction

Speaker: Doctor D. Delialis (Athens, GR)

Access
Abstract
Slides
Like
Thumbnail

Effect of metabolic syndrome on mean platelet volume and relationship to extent of coronary artery disease.

Speaker: Doctor E. Sdogkos (Veria, GR)

Access
Abstract
Slides
Like
Thumbnail

Unlocking the mystery. Exploring the relationship between PFO anatomical features and the right to left shunt size

Speaker: Doctor D. Maritsa (London, GB)

Access
Abstract
Like
Thumbnail

Red cell distribution width - prognostic parameter that could be used in heart failure patients

Speaker: Doctor A. Catana (Bucharest, RO)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 3 - Understanding cardiovascular risk development: novel mechanisms (2)

Speakers: Mr F. Qhabibi, Doctor D. Delialis, Doctor E. Sdogkos, Doctor D. Maritsa, Doctor A. Catana
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources